Cargando…
Considerations for diagnostic COVID-19 tests
During the early phase of the coronavirus disease 2019 (COVID-19) pandemic, design, development, validation, verification and implementation of diagnostic tests were actively addressed by a large number of diagnostic test manufacturers. Hundreds of molecular tests and immunoassays were rapidly devel...
Autores principales: | Vandenberg, Olivier, Martiny, Delphine, Rochas, Olivier, van Belkum, Alex, Kozlakidis, Zisis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556561/ https://www.ncbi.nlm.nih.gov/pubmed/33057203 http://dx.doi.org/10.1038/s41579-020-00461-z |
Ejemplares similares
-
Laboratory-Based and Point-of-Care Testing for MSSA/MRSA Detection in the Age of Whole Genome Sequencing
por: van Belkum, Alex, et al.
Publicado: (2018) -
Editorial: Clinical Microbiology in Low Resource Settings
por: Kozlakidis, Zisis, et al.
Publicado: (2020) -
Immunological considerations for laboratory staff and COVID-19 biosafety
por: Kintossou, Ambroise Kouame, et al.
Publicado: (2023) -
Control of Infectious Diseases in the Era of European Clinical Microbiology Laboratory Consolidation: New Challenges and Opportunities for the Patient and for Public Health Surveillance
por: Vandenberg, Olivier, et al.
Publicado: (2018) -
The incidence of Coronavirus disease 2019 (COVID-19) among vaccinated healthcare workers (HCWs): evidence for protection from hospitalisation from an Indonesian cohort
por: Kozlakidis, Zisis
Publicado: (2023)